Cite
Torrente-Segarra V, Urruticoechea Arana A, Sánchez-Andrade Fernández A, et al. RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database. Mod Rheumatol. 2015;26(3):336-341doi: 10.3109/14397595.2015.1101200.
Torrente-Segarra, V., Urruticoechea Arana, A., Sánchez-Andrade Fernández, A., Tovar Beltrán, J. V., Muñoz Jiménez, A., Martínez-Cristóbal, A., González Ferrández, J. A., Fernández Prada, M., Vázquez Fuentes, N., Corominas, H., García-Díaz, S., Acosta Pereira, A., Ruiz Martín, J. M., Lamua Riazuelo, J. R., Expósito Moliner, R., Ruiz Vilchez, D., Veiga Cabello, R., Fernández, J. C., Noguera Pons, J. R., Garrido Puñal, N. P., Giralt Celiméndiz, P., Cortés Verdú, R., Aragón Díez, A., Tomás Roura, C., Moll Turudi, C., Taverner Torrent, D., Rivas Santirso, F. J., Lerma Garrido, J. J., García Portales, R., Ordoñez Palau, S., Paredes González-Albo, S., Gracia Pérez, A., Conesa Mateos, A., Calvo Alén, J., Graña Gil, J., Navarro Alonso, M. P., Martínez Blasco, M. J. (2016). RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database. Modern rheumatology, 26(3), 336-341. https://doi.org/10.3109/14397595.2015.1101200
Torrente-Segarra, Vicenç, et al. "RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database." Modern rheumatology vol. 26,3 (2016): 336-341. doi: https://doi.org/10.3109/14397595.2015.1101200
Torrente-Segarra V, Urruticoechea Arana A, Sánchez-Andrade Fernández A, Tovar Beltrán JV, Muñoz Jiménez A, Martínez-Cristóbal A, González Ferrández JA, Fernández Prada M, Vázquez Fuentes N, Corominas H, García-Díaz S, Acosta Pereira A, Ruiz Martín JM, Lamua Riazuelo JR, Expósito Moliner R, Ruiz Vilchez D, Veiga Cabello R, Fernández JC, Noguera Pons JR, Garrido Puñal NP, Giralt Celiméndiz P, Cortés Verdú R, Aragón Díez A, Tomás Roura C, Moll Turudi C, Taverner Torrent D, Rivas Santirso FJ, Lerma Garrido JJ, García Portales R, Ordoñez Palau S, Paredes González-Albo S, Gracia Pérez A, Conesa Mateos A, Calvo Alén J, Graña Gil J, Navarro Alonso MP, Martínez Blasco MJ. RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database. Mod Rheumatol. 2016 May;26(3):336-341. doi: 10.3109/14397595.2015.1101200. Epub 2015 Nov 07. PMID: 26418571.
Copy
Download .nbib